Status:
COMPLETED
Dose Response Trial of Pergolide for Cocaine Dependence - 1
Lead Sponsor:
Medical University of South Carolina
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Cocaine-Related Disorders
Eligibility:
All Genders
21-50 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the efficacy and safety of pergolide for treatment of cocaine dependence.
Eligibility Criteria
Please contact site for information.
Key Trial Info
Start Date :
February 1 1996
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000248
Start Date
February 1 1996
Last Update
May 16 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of South Carolina
Charleston, South Carolina, United States, 29425 742